Mark Peterson, MD
Orthopedic Surgery · Rockville, MDNPI 1740226430
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (51.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 50.2% of the total. Reporting peaked in 2019 at $5,858 and has fallen 82.2% since, to $1,044 in 2025.
Across 67 payments — averaging $189.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$6K
- Arthrex$5K
- Stryker$691
- Hikma Pharmaceuticals USA$344
- Smith+Nephew$232
- Amgen$125
- plus $369 from 6 others
What the payments were for
- Consulting fees$3443%
- Travel & lodging$3,63529%
- Food & beverage$2,16117%
- Education$6,55852%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 21 | $6,372 |
| Arthrex | 19 | $4,565 |
| Stryker | 14 | $691 |
| Hikma Pharmaceuticals USA | 1 | $344 |
| Smith+Nephew | 4 | $232 |
| Amgen | 1 | $125 |
| Sanara Medtech Inc. | 1 | $121 |
| Johnson & Johnson | 1 | $116 |
| Zimmer Biomet | 1 | $45 |
| Fidia Pharma USA Inc. | 2 | $36 |
| Moximed, Inc | 1 | $33 |
| Genentech USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$385
- COMBOGESIC IV$344
- NA$232
- KRYSTEXXA$125
- CellerateRx$121
- VA-LCP$116
How this compares
$12,697 in reported general payments places this provider in the 85th percentile of 24 orthopedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 33 | $1,313 |
| Diclofenac Sodium | 27 | $505 |
| Oxycodone Hcl | 78 | $407 |
| Tramadol Hcl | 83 | $265 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 59 | $236 |
| Methylprednisolone | 28 | $185 |
| Cefadroxil | 17 | $128 |
| Pantoprazole Sodium | 13 | $90 |
| Pregabalin | 14 | $89 |
| Gabapentin | 11 | $70 |
| Amoxicillin | 17 | $19 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Rockville
- Christopher CannovaBethesda$1.6M
- Craig MillerBethesda$72K
- Jason KinneyBaltimore$22K
- Akachimere UzosikeBaltimore$12K
- James MurphyGlen Burnie$2K
- Andrew SiekanowiczSilver Spring$2K
- Benjamin KnoxEaston$2K
- Olumuyiwa PaulGlenn Dale$1K
- Mark PfaffElkton$1K
- Roy BandsAnnapolis$917
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.